Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Gestational Diabetes
Interventions
DIAGNOSTIC_TEST

Continuous glucose monitoring (CGM)

Continual use of CGM to monitor blood glucose levels from enrollment through delivery admission \& discharge + additional 10 days during postpartum period

DIAGNOSTIC_TEST

Self-Capillary Blood Glucose Monitoring (SCBG)

Conventional SCBG 4x/day testing (standard care in Oregon; fasting and 1-hour postprandial) with blinded CGM every 2 weeks SCBG 4 times/day until delivery admission 10 days duration with each blinded CGM wear

Trial Locations (1)

97239

OHSU, Portland

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Oregon Health and Science University

OTHER

NCT04605497 - Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus | Biotech Hunter | Biotech Hunter